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http://www.biomedcentral.com/1471-244X/14/117RESEARCH ARTICLE Open AccessExercise therapy in adults with serious mental
illness: a systematic review and meta-analysis
Robert Pearsall1, Daniel J Smith2*, Anthony Pelosi3 and John Geddes4Abstract
Background: Individuals with serious mental illness are at a higher risk of physical ill health. Mortality rates are at
least twice those of the general population with higher levels of cardiovascular disease, metabolic disease, diabetes,
and respiratory illness. Although genetics may have a role in the physical health problems of these patients, lifestyle
and environmental factors such as levels of smoking, obesity, poor diet, and low levels of physical activity also play
a prominent part.
Methods: We conducted a systematic review and meta-analysis of randomised controlled trials comparing the effect of
exercise interventions on individuals with serious mental illness.
Searches were made in Ovid MEDLINE, Embase, CINAHL, PsycINFO, Biological Abstracts on Ovid, and The Cochrane
Library (January 2009, repeated January 2013) through to February 2013.
Results: Eight RCTs were identified in the systematic search. Six compared exercise versus usual care. One study
assessed the effect of a cycling programme versus muscle strengthening and toning exercises. The final study
compared the effect of adding specific exercise advice and motivational skills to a simple walking programme.
The review found that exercise improved levels of exercise activity (n = 13, standard mean difference [SMD] 1.81,
CI 0.44 to 3.18, p = 0.01). No beneficial effect was found on negative (n = 84, SMD = −0.54, CI −1.79 to 0.71, p = 0.40) or
positive symptoms of schizophrenia (n = 84, SMD = −1.66, CI −3.78 to 0.45, p = 0.12). No change was found on body mass
index compared with usual care (n = 151, SMD =−0.24, CI −0.56 to 0.08, p = 0.14), or body weight (n = 77, SMD = 0.13,
CI −0.32 to 0.58, p = 0.57). No beneficial effect was found on anxiety and depressive symptoms (n = 94, SMD =−0.26,
CI −0.91 to 0.39, p = 0.43), or quality of life in respect of physical and mental domains.
Conclusions: This systematic review showed that exercise therapies can lead to a modest increase in levels of exercise
activity but overall there was no noticeable change for symptoms of mental health, body mass index, and body weight.
Keyword: Exercise, Physical activity, Serious mental illness, Healthy living programme, Physical healthBackground
There is now a greater focus on patients’ physical health
by mental health services [1]. People with serious mental
illness have consistently higher levels of mortality and
morbidity than the general population. Mortality rates
remain persistently high around twice those of the gen-
eral population [2]. The life expectancy of people with
serious mental illness is shortened by between 11 and
18 years [3]. Despite a steady reduction in mortality
rates in the general population no significant change has
been observed in people with serious mental illness [4].* Correspondence: daniel.smith@glasgow.ac.uk
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unless otherwise stated.The widening differential gap in mortality suggests that
people with schizophrenia have not fully benefited from
the improvements in health outcomes available to the
non-mentally ill population [2].
The underlying causes for the health problems of this
population are both complex and multi-factorial [5].
People with serious mental illness such as schizophrenia
have higher levels of cardiovascular disease [6,7], metabolic
disease [8], diabetes [9,10], and respiratory illness [11,12].
Although genetics may have a role in the physical health
problems of these patients, lifestyle and environmental fac-
tors such as smoking, obesity, poor diet, and low levels ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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treatments given to people with serious mental illness con-
tribute to the health problems in this population. For
example, neuroleptic medication can lead to significant
metabolic problems such as weight gain, lipid abnor-
malities, and changes in glucose regulation [14]. Evi-
dence is becoming clearer that long term exposure to
these medications may contribute to the higher mor-
tality levels in this population [5].
There is now a greater focus on attempting to improve
the physical health of these patients. However they have
less access to medical care, poorer quality of care, and
preventative health checks are less commonly completed
in both primary and secondary care compared with the
general population [15-17]. The nature of their mental
illness may also affect their motivation as many individ-
uals may be not ready to change their lifestyle [18,19].
Individuals with serious mental illness have higher levels
of smoking, weight problems, poor dietary intake, and
low levels of physical activity. Rates of smoking of up
to 70% have been found in patients with schizophrenia
[7,20,21]. The prevalence of smoking in the general
population is approximately 20% [22]. Individuals with
serious mental illness have a poorer diet than the non-
mentally ill population [20,23]. Levels of obesity range
from 40-60%, up to four times that of the non-mentally
ill population [24-26]. These individuals are less active
with lower levels of physical activity compared with
the general population [27-29].
Regular physical activity has been found to be benefi-
cial for both physical and mental health in the general
population. There is a direct relationship between physical
activity and a reduction in cardiovascular disease, cerebro-
vascular disease, stroke, and hypertension [30,31]. Physical
activity also leads to a reduction in the risk of metabolic
health problems such as diabetes and metabolic syndrome
[30]. A routine level of at least 150 minutes of physical
activity per week is required to achieve a consistent re-
duction in risk [31]. In the general population about
60% of men and 70% of women self-report less than
the recommended levels and objective measures of
activity suggest that far more of these individuals are
failing to meet the recommendations [32]. Physical ac-
tivity has beneficial effects on mental health. It has
been shown to be effective in the treatment of depres-
sion [33] and anxiety disorders [34]. It has positive ef-
fects on psychological well-being [35], quality of life
[36] and in the reduction of stress [37].
The aim of this review was to determine the effective-
ness of exercise programmes for people with serious
mental illness. Two main objectives of this review were
to firstly determine the effect of these programmes on
levels of exercise activity, and secondly the effect of exer-
cise on mental health and well-being.Methods
Eligibility criteria
Studies met the following criteria for inclusion in the
review:
1. Adults with schizophrenia or other types of
schizophrenia-like psychosis, schizoaffective
disorders, and bipolar affective disorder irrespective
of the diagnostic criteria used, age, ethnicity and sex.
2. All patients, adults, clients, in the community or in
hospital.
3. All relevant randomised controlled trials.
4. Interventions where a primary or secondary aim was
to promote exercise or physical activity.
Search Methods, and study selection
We searched the following electronic databases: Ovid
MEDLINE, Embase, CINAHL, PsycINFO, Biological
Abstracts on Ovid, and The Cochrane Library (January
2009, repeated May 2013). The systematic search included
hand searching of journals, books, cross-referencing and
bulletins (e.g. brief reports/brief statement of facts). The
search filter, the Cochrane Highly Sensitive Search Strategy,
was used to assist in the identification of randomised trials
in MEDLINE [38].
The abstracts of studies were examined by RP. Full
text of the studies that potentially met the eligibility cri-
teria was obtained. Discrepancies were discussed with
co-investigators. We checked articles that met the inclu-
sion criteria for duplication of the same data.
Data extraction and analysis
Data was extracted by one author (RP) and checked for ac-
curacy by the second (DS). Data was extracted onto pre-
pared forms to include: participants and setting, location,
description of the intervention, type of exercise, study size,
methodological issues, risk of bias, results, and general
comments. All analyses were conducted using Revman
Manager version 5.1. We performed a PRISMA evaluation
of our meta-analysis using a standard checklist of 27 items
that ensure the quality of a systematic review or meta-
analysis [39]. A summary measure of treatment effect was
used as different outcome measures were found. The stan-
dardized mean difference (SMD) with 95% confidence in-
tervals was calculated as the difference in means between
groups divided by the pooled standard deviation. If no
standard deviations were found they were calculated from
standard errors, confidence intervals, or t values [40].
Authors were contacted for missing data if analyses could
not be completed. Statistical heterogeneity was assessed by
the I2 test. The degree of heterogeneity was categorised as
the following [36]: 0% to 40% low level of heterogeneity;
30% to 60% moderate heterogeneity; 50% to 90% substantial
heterogeneity; 75% to 100%: considerable heterogeneity.
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effects model as this would take into account any differ-
ences between studies even if there was no statistically
significant heterogeneity [40].
Quality assessment
There is no agreed standardised method to assess the
quality of studies in systematic reviews. We adapted the
Cochrane Collaboration’s tool for assessing the risk of
bias [40]. The following recommended domains were
considered: sequence generation, allocation conceal-
ment, blinding, incomplete outcome data, selective out-
come reporting, and other sources of bias. Each item
was rated according to the level of bias and categorised
into either low, high, or unclear. The category unclear
indicated unclear or unknown risk of bias [40].
Results
The electronic search identified 1284 potentially eligible
reports. Nine hundred and thirty two were excluded on
the basis of the title or abstract alone. We retrieved the
full text of 216 articles and excluded a further 209 stud-
ies. The review excluded a large number of studies as
they included additional components such as dietary or
weight programmes (Figure 1).Records identified through database 
searching
(n = 1284)
Records screened
(n =1314)
Full-text articles assessed for 
eligibility
(n = 216)
Studies included in quantitative 
synthesis (meta-analysis)
(n = 8)
Figure 1 Flowchart of the results of the systematic search.All included studies had been published between 2005
and 2013. The studies varied in their setting, size, age,
study intervention type, and use of outcome measures.
Study characteristics
Characteristics of the sample, interventions, outcomes
assessment and results are shown in Tables 1, 2 and 3.
Setting and participant characteristics
Eight studies met the inclusion criteria. Of these 5 were
based solely in either a community or outpatient setting.
The remainder comprised a combination of inpatient
hospital together with community or outpatient pro-
grammes. Diversity of setting may have had an impact
on the delivery and generalisability of the exercise inter-
ventions. Exercise change may be more easily achievable
within a more closely supervised setting such as an in-
patient ward. The sample size of studies in this review
varied considerably. The largest study had 118 patients
in their programme the smallest 10 individuals. The
mean age of individuals ranged from 27 years to 52 years.
The majority were in the age group 30–40 years. One
study [41] used an older age population with a mean age
of 46.9 years and one a younger group with a mean of
29.2 years [42]. The variation in age group may have* some excluded for several reasons
Records excluded
(n = 209)
Full-text articles excluded, with reasons
(n =209)*
Not randomised design n=180
Yoga programmes n=3
Additional lifestyle intervention n= 27
Additional records identified through 
other sources
(n =31)
Records after duplicates removed
(n = 327)
Table 1 Systematic review – exercise interventions (Description of programmes)
Study Study outline Description of intervention
Beebe et al. [41] Study to assess the effectiveness of an exercise programme on
the physical and mental health of individuals with
schizophrenia.
Intervention to determine whether an exercise programme can
improve the physical and mental health of individuals with
schizophrenia.
12 participants, random allocation to two groups, intervention
and control group (randomisation schedule by statistician).
16 week intervention.
Intervention group – treadmill exercise programme, meeting 3
times/week for 16 weeks. Programme consisted 10 minutes
warm-up session, treadmill walking, then 10 minutes of cool-
down exercises. Treadmill walking session gradually increased
from 5 minutes to 30 minutes per episode for rest of study.
Control Group – no exercise programme offered to this group,
until end of study.
Attendance – 43% to 91% of total sessions offered, 75%
attended half of sessions, 50% attended 2/3.
Assessments – demographics, weight/ height/ BMI, 6-Minute
Walking Distance (6 MWD), Percentage Body Fat, Positive and
Negative Syndrome Scale Scores (PANSS).
Skrinar et al. [45] Study to assess the impact of an exercise programme
in individuals with serious mental illness.
Intervention of patients with mood and psychotic illness. To
determine the effect of a 12 week exercise programme on
physical and mental health measures.
12 week programme. 2 groups - intervention group and control
group. Patients randomly assigned.
Intervention group – 4 exercise per week for 12 weeks + one
health seminar per week. Aerobic and cardiovascular training
and cool-down each session, increasing intensity of exercise.
Health seminar topics – healthy eating, weight management,
stress relief, spirituality and wellness.
Control group – normal care, although offered exercise
programme end of study + asked to keep record of amount of
exercise they will do during control phase.
Assessments – demographics, weight, height, pulse, blood
pressure, blood tests, Symptom Checklist- 90- R, Lehman Quality
of Life Questionnaire, Boston University Making Decisions
Questionnaire, MOS 36- Item Short-Form Health Survey (SF- 36).
Pre and post-intervention assessment.
Acil et al. [47] Study to determine the of 10 week exercise programme
v. control, in patients with schizophrenia.
10 week programme using intervention and control group. Mixed
group of inpatients and outpatients. Randomised two groups.
Intervention group – 10 week, 3 days per week, and 40 min.
per intervention session.
Aerobic exercise programme for first 2 weeks with 25 min. per
day. Starts with 10 min. work up then 25 min. aerobic exercise.
Finally 5 min. cooling down.
Control group – no details of control group.
Baseline assessment – following assessments:- demographic
data, heart rate, Scale for Assessment for Negative Symptoms
(SANS), Scale for the Assessment of Positive Symptoms (SAPS),
Brief Symptom Inventory (BSI), World Health Organization
Quality of Life Scale-Turkish Version (WHOQOL-BREF-TR).
Marzolini et al. [46] Study to assess the effectiveness of an exercise programme
for individuals with schizophrenia.
Intervention to determine the efficacy of a group-based exercise
programme. Multidisciplinary approach using a resistance and
aerobic exercise programme.
Intervention over 12 weeks. 2 groups, exercise group and usual
care (control). Randomised allocation.
Intervention – exercise twice per week for 12 weeks at local
recreation centre + once per week additional aerobic exercise
session individually or during home-visit from mental health
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Table 1 Systematic review – exercise interventions (Description of programmes) (Continued)
clinician. Advised to exercise to same pace and duration at
home.
Control Group – “usual care” continued. No other intervention
except measurement at baseline and 12 weeks.
Assessments – demographic history, weight/BMI, waist/hip
circumference, resting blood pressure, functional exercise capacity
(6-Minute Walking Distance), muscular strength (one repetition
maximum test), anthropometric measurements, adherence to
exercise tests, Mental Health Inventory (MHI), self designed
feedback questionnaire.
Beebe et al. [43] Study to determine the effect of effect of exercise advice and
techniques, motivational interviewing skills, and a walking
programme compared with the control comprising a walking
group only in people with schizophrenia spectrum disorders.
Randomised controlled trial of an intervention to effect of exercise
advice and techniques, motivational interviewing skills, and a
walking programme compared with the control, comprising a
walking group only - in people with schizophrenia spectrum
disorders. 16 week walking programme with intervention and
control group. WALC-P versus TAC
Intervention – WALC-S programme – Walk (discuss walking/
information/advice), Address Sensations (discussion about
discomforts warming up or cooling down, suggestions to
minimise problems), Learn about Exercise (information on
exercise benefits and barriers), Cue Exercise (calendars or
times to start walking, with reminder calls etc.).
Control group – TAC group (time and attention control) consisted
of 4 weekly, 1 hour (8–9 subjects per group) – focussing on
health behaviour, smoking, relaxation, medication adherence.
All patients attended walking group for 16 weeks. Assessments –
demographic data, walking group attendance, walking group
persistence and compliance.
Methapatara et al.
[44]
Study to examine the effects of a walking programme in
individuals with schizophrenia.
Study to compare the effects of a walking programme
combined with motivational interviewing in patients with
schizophrenia who are overweight or obese.
Randomised open label, parallel controlled trial of 12 week
duration. Patients with schizophrenia with a BMI of 23 kg/m2.
Intervention compared with the control in ratio 1:1. Programme
started pre-discharge in hospital for 1 week. Advised to increase
walking post-discharge.
Intervention Group – five 1 hour sessions. Individual motivational
interviews given at first session focussing on adequate daily walking.
Second session involved group education on nutrition, exercise,
warming up, cooling down, and start of use of pedometers.
Minimum of 3000 steps per day recommended level of walking.
Fourth session group walking. Individuals encouraged to
increase walking at other times. Fifth session – feedback on
programme/progress.
Control Group – received usual care only. No pedometer given.
Assessments demographics,, body weight, waist circumference,
CGI-Severity, MMSE-Thai.
Scheewe et al. [42] Study to assess the effectiveness of exercise therapy on
cardiorespiratory fitness (CRF) in individuals with schizophrenia.
Intervention to study the effect of an exercise intervention on CRF
in patients with schizophrenia compared with matched controls.
Trial part of the TOPFIT project. Twenty four week programme.
Sixty-three patients with schizophrenia and 55 controls randomised.
Randomisation computer generated, stratified for gender,
recruitment site and BMI. Four centres, community recruitment.
Intervention – 1:1 allocation of exercise or occupational therapy.
Exercise consists of cycling, rowing, hiking and muscle exercises.
Two times a week for 1 hour. Occupational therapy consisted of
computer operations, drawing, sculpting and painting.
Control group - exercise or life as usual. Assessments – Scheewe
et al., 2012: CRF assessed using a Cardiopulmonary exercise test
(CPET) – stepwise incremental protocol to exhaustion on an
upright cycle ergometer. Terminated at voluntary exhaustion.
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Table 1 Systematic review – exercise interventions (Description of programmes) (Continued)
Physiological measurements – blood pressure, heart rate, oxygen
update, peak minute ventilation. Scheewe et al., 2013: PANSS,
MADRS, Camberwell Assessment of need (CAN), body mass index,
waist circumference, blood pressure, blood parameters.
Scheewe et al., 2013: Global brain volumes, hippocampal
volume, and cortical thickness.
Pelham et al. [48] Study to assess the impact of an exercise programme in
individuals with serious mental illness.
Intervention to assess the effect of an exercise programme using
cycling as the method of exercise activity compared to a control.
12 week programme. Eight patients with schizophrenia and 2
with bipolar affective disorders. Total 10 patients in programme.
Randomisation into two equal groups. Based in psychiatric
rehabilitation services.
Intervention – exercise activity on a cycle ergometer. Four sessions
per week for 30 minutes at 65% to 75% of heart rate reserve.
Control – muscle tone and strengthening exercises, 4 times per
week for 30 minutes each session. Short intermittent bouts used
within this to keep heart rate below 110 beats per minute.
Assessments – VO2 max tests, Becks Depression Inventory,
and weight measurements.
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population may have been more able to improve their level
of exercise. The ethnicity of participants was described in
only two studies. Beebe et al. [43] found that 54% of partici-
pants were Caucasian, 44% African-American, while Beebe
et al. [41] in a small study of 10 participants, 80% were
Caucasian and 20% African-American.
Exercise interventions
Each study used a different type of aerobic exercise in-
corporating cardiovascular exercise and resistance train-
ing. Three studies used walking as their exercise activity
[41,43,44], while four studies used a combination of general
aerobic and cardiovascular exercise [42,45-47]. Cycling was
the method of exercise activity used in the remaining study
[48]. In addition to the exercise activity general information
was given to all participants about exercise. Only two stud-
ies used more specific advice and guidance [43,45]. Skrinar
et al. [45] offered seminars on a range of topics such as
adequate individual levels of exercise, healthy eating, stress
relief, spirituality and wellness. In the remaining study
Beebe et al. (2011) compared the effect of adding specific
exercise advice and motivational skills to a simple walking
programme [43].
Only one study [42] used a standardised programme
of exercise comprising of cardiovascular and muscle
strength exercises [49]. Moderate levels of exercise in-
tensity were described in 7 out of the 8 programmes.
Only Methapatara et al. [44] described the specific
amount of exercise activity used in their programme.
The actual amount or dose of exercise activity was not
measured in the remaining studies.
Each programme varied in their frequency and dur-
ation. Some were twice a week [46] while Skrinar et al.
[45] described a programme 4 times per week. Theduration of the programmes lasted between 10 weeks
[47] to 24 weeks [42].
Outcomes
A variety of different outcome measures were used
(Table 4). This made it especially difficult to compare the
results of individual interventions. Two studies used a vali-
dated measure of exercise, namely the 6-Minute Walking
Distance [41,46]. Others used measures such as body mass
index [46], the number of exercise sessions attended [45],
or the number of minutes walked [43].
Six studies compared the effect of exercise with usual
care. A significant increase in the distance walked in
6 minutes was found in one RCT (n = 13, SMD = 1.81,
CI 0.44 to 3.18, z = 2.58, p = 0.01) (Figure 2) [46]. A
small non-significant reduction was found on body
mass index (n = 151, SMD = −0.24, CI −0.56 to 0.08,
p = 0.14; heterogeneity, Chi2 = 1.45, I2 = 0%, p = 0.69)
(Figure 3). No effect was found comparing the effect of
exercise on body weight (n = 77, SMD = 0.13, CI −0.32
to 0.58, p = 0.57; heterogeneity, Chi2 = 0.07, I2 = 0%,
p = 0.79) (Figure 4).
There was no overall beneficial effect on negative symp-
toms (n = 84, SMD=−0.54, CI −1.79 to 0.71, p = 0.40) or
positive symptoms of schizophrenia (n = 44, SMD= −1.66,
CI −3.78 to 0.45, p = 0.12). Exercise did not lead to an im-
provement in anxiety and depressive symptoms (n = 94,
SMD= −0.26, CI −0.91 to 0.39, p = 0.43; heterogeneity,
Chi2 = 3.92, I2 = 49%, p = 0.14) (Figure 5).
Data from single RCTs was available for the following
outcome measures. Overall, there was no clear evidence
that exercise interventions led to significant improve-
ments in quality of life. A small non-significant increase
in points of physical and mental domains were found
(physical domain: n = 30, SMD = 0.45, CI −0.27 to 1.18,
Table 2 Systematic review – exercise interventions (Methodological issues/Risk of bias)
Study Country Participants & setting Design Recruitment Baseline
sample
Number
completing
trial
Methodological issues/Risk of bias
Beebe et al. [41] USA Patients attending outpatient clinic
at a Veterans Hospital
RCT Volunteers 12 10 Participants – eligibility criteria specified - yes
- standardised diagnostic criteria - Yes
- non-random recruitment
- similar baseline groups
Intervention – details of therapists training not indicated
- no treatment manual
- compliance of medication non- checked
Measurement of Outcome
- outcome assessors blinded to treatment allocation
- adequate follow- up period
Risk of Bias - adequate sequence generation- unclear
allocation concealment- unclear
blinding of participants, personnel and outcome assessors - yes
incomplete data outcome - yes
free of selective outcome reporting- yes
free of other sources of bias- yes
Small sample, majority male, control group awareness of exercise
programme.
Attendance at sessions variable.
Skrinar et al. [45] USA Patients from inpatient, partial
hospitalisation, outpatient and
community centres in area of
McLean Hospital.
RCT Selection/ invitation 30 20 Participants – eligibility criteria specified - yes
- standardised diagnostic criteria -yes
- non-random recruitment
- similar baseline groups –
Intervention – details of therapists training not indicated
- no treatment manual
Measurement of Outcome
- outcome assessors not blinded to treatment allocation
- adequate follow- up period
Risk of Bias - adequate sequence generation - unclear
allocation concealment - unclear
blinding of participants, personnel and outcome assessors - no
incomplete data outcome - no
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Table 2 Systematic review – exercise interventions (Methodological issues/Risk of bias) (Continued)
free of selective outcome reporting - yes
free of other sources of bias - yes
Small sample, variable adherence to programme and attendance,
inclusion criteria include mood disorders as well.
Control group may be affected by exercise “influence” of study.
Acil et al. [47] Turkey Inpatient and outpatient. Diagnosis
of schizophrenia
RCT Recruitment method
not described, 30
outpatients and
inpatients.
30 30 Participants – eligibility criteria poorly specified
- standardised diagnostic criteria- yes
- non-random recruitment
- similar baseline group
Intervention – details of therapists training not indicated
- no treatment manual
Measurement of Outcome
- outcome assessors not blinded
- adequate follow- up period
Risk of Bias - adequate sequence generation - no
allocation concealment - no
blinding of participants, personnel and outcome assessors - no
incomplete data outcome - unclear
free of selective outcome reporting - unclear
free of other sources of bias - yes
Non-standardized exercise intervention. No measurement of
existing exercise level or patient participation in the programme.
Number completed trial not given.
Marzolini et al. [46] Canada Identified from Community Mental
Health Programme. Majority lived
supported accommodation.
RCT Volunteers 13 13 Participants – eligibility criteria specified - yes
- standardised diagnostic criteria -yes
- non-random recruitment
- similar baseline groups –
Intervention – details of therapists training not indicated
- no treatment manual
Measurement of Outcome
- outcome assessors not blinded to treatment allocation
- adequate follow- up period
Risk of Bias - adequate sequence generation - yes
allocation concealment - yes
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Table 2 Systematic review – exercise interventions (Methodological issues/Risk of bias) (Continued)
blinding of participants, personnel and outcome assessors -
unclear
incomplete data outcome - no
free of selective outcome reporting - yes
free of other sources of bias - yes
Small sample, participants supported accommodation. Inclusion
criteria – patients had to have one or more cardiovascular risk factors.
Beebe et al. [43] USA Outpatients RCT Volunteers 97 79 Participants – eligibility criteria specified
- standardised diagnostic criteria
- non-random recruitment
- similar baseline groups
Intervention – details of therapists training indicated
- treatment manual - yes
- compliance of medication non- not checked
Measurement of Outcome
- outcome assessors not blinded to treatment allocation
- adequate follow- up period
Risk of Bias - adequate sequence generation - yes
allocation concealment - unclear
blinding of participants, personnel and outcome assessors -
unclear
incomplete data outcome - unclear
free of selective outcome reporting - yes
free of other sources of bias - yes
Well-designed programme. Adequate sample size.
No assessment of mental health changes - improvement in mental
health may have contributed to increase in exercise by itself.
Methapatara et al. [44] Thailand Inpatient & Outpatients RCT Volunteers 64 64 Participants – eligibility criteria specified
- standardised diagnostic criteria – not indicated
- volunteers
- dissimilar baseline groups –
younger control population
Intervention – details of therapists training not indicated
- treatment manual - no
- compliance of medication not checked
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Table 2 Systematic review – exercise interventions (Methodological issues/Risk of bias) (Continued)
Measurement of Outcome
- outcome assessors blinded to treatment allocation
- adequate follow- up period
Risk of Bias - adequate sequence generation - yes
allocation concealment - yes
blinding of participants, personnel and outcome assessors - no
incomplete data outcome - yes
free of selective outcome reporting - yes
free of other sources of bias - yes
Small sample size, no record of daily steps recorded or
measurement of change in exercise levels. Compliance with
programme unknown (as no recording of pedometer). No
assessment of nutritional intake which may have affected
outcome. Effect on mental health unknown.
Scheewe et al. [42] USA Community RCT Volunteers 118 92 Participants – eligibility criteria specified - yes
- standardised diagnostic criteria – not indicated
- non-random recruitment
- dissimilar baseline groups
Intervention – details of therapists training indicated
- treatment manual
Measurement of Outcome
- outcome assessors not blinded to treatment allocation
- adequate follow-up period
Risk of Bias - adequate sequence generation - yes
allocation concealment - yes
blinding of participants, personnel and outcome assessors - no
incomplete data outcome - unclear
free of selective outcome reporting - yes
free of other sources of bias - yes
Well-designed programme. Large sample size. Computer
generated randomisation. Study part of larger research trials. No
results from mental health assessment. Baseline group differences.
Mean weight greater in patients than controls. Motivated group of
patients with higher level of fitness at baseline. No follow up of
participants to show whether improvement in exercise
maintained.
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Table 2 Systematic review – exercise interventions (Methodological issues/Risk of bias) (Continued)
Pelham et al. [48] USA Community Rehabilitat-ion RCT Volunteers 10 10 Participants – eligibility criteria specified - yes
- standardised diagnostic criteria – not indicated
- non-random recruitment
- baseline groups unclear
Intervention – details of therapists training indicated - no
- treatment manual- no
Measurement of Outcome
- outcome assessors not blinded to treatment allocation
- adequate follow-up period
Risk of Bias - adequate sequence generation - unclear
allocation concealment - unclear
blinding of participants, personnel and outcome assessors - no
incomplete data outcome - unclear
free of selective outcome reporting - unclear
free of other sources of bias – unclear
Small study. Control also using exercise activity. Data not available
to include in meta-analysis. Early study 21 years ago. Beneficial
effects on exercise fitness and depression scores.
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Table 3 Systematic review – exercise interventions (Results/Comments)
Study Results Comments/Analysis
Beebe et al. [41] 6-Minute Walking Distance (MWD) – improvement in distance clinically (152.5 mins)
compared with the control group (56.7 mins), but not statistically significant. BMI and body
fat reduced in intervention group compared with the control group but not statistically
significant. Control Group – increased 6- MWD during intervention (5%).
Valuable study, limited by small sample, population type. Control group showed
some increase in physical activity (? overlap effect of intervention).
Skrinar et al. [45] Weight change intervention: control −2.2 v. -1.2 kg (non-significant). Exercise intensity
increased in intervention compared with the control + 8 Watts v. -5 Watts (non-significant).
Significant improvement in results in general health (p < 0.05) and empowerment (p < 0.01).
Valuable study although some limitations in methodology.
Acil et al. [47] Exercise programme resulted in decrease in psychiatric symptoms and increase in quality of
life. Reduced SANS, SAPS and BSI. Increase in WHOQOL-BREF-TR. No exercise measures
change of heart rate. Demographic data not provided.
Valuable intervention study, however limited by small sample size, and lack of
standardization of intervention. No details of drop-out rate or measurement of
exercise levels in subjects.
Marzolini et al. [46] Mean age 43 years. Exercise group showed a 27.7 metre (SD ± 22.3 m) increase in 6MWD
while control group showed decrease of 28.3 metres (SD ± 26.6 m) (between group
difference, p = 0.1). There was significant increase in strength exercise and Mental Health
Inventory. Attendance averaged 72% (SD ± 4.4%) with no dropouts.
Valuable study but limited by small sample size. Good adherence to programme.
Beebe et al. [43] Percentage attendance in WALC-S group 35.2 versus 27.3% after 16 week programme. 33.7
versus 22.9 in TAC group. Greater persistence in weeks in WALC-S versus TAC, and higher
minutes walked (76.67 versus 116.89) in WALC-S group, and (61.88 versus 788.83) in TAC
group.
Well-designed study indicating the benefit of exercise advice with a motivational
programme in addition to exercise intervention.
Methapatara et al. [44] End of programme, mean body weight decreased significantly compared with the control
group by 2.21 kg (p = 0.03).
Valuable study showing the benefit of an exercise programme in overweight or
obese patients with schizophrenia.
Scheewe et al. [42] Patients had higher resting HR, lower pear HR, peak systolic BP, relative VO2 peak, Wpeak, RER,
minute ventilation, and HR recovery than controls. In conclusion patients had lower CRF
levels compared with controls. Exercise therapy increased VO2 peak, and Wpeak in patients
and controls. VO2 peak, and Wpeak decreased in non-exercising patients.
Well-designed study. Results show an increase in CRF in individuals with
schizophrenia. However individuals may be more motivated and have greater
baseline fitness than many individuals with this illness.
Trend-level effect on depressive symptoms (p = 0.07). No effect on symptoms of
schizophrenia.
Significantly smaller baseline cerebral (gray) matter, and larger third ventricle volume,
thinner cortex. NO change global brain, hippocampal volume, or cortical thickness.
Pelham et al. [48] Aerobic exercise group showed significant increases in fitness and a reduction in
depression scores. Non-aerobic groups did not improve in fitness level or level of
depression.
Small study of 10 patients. Conducted 21 years ago. Findings showed the
possible positive effects of exercise on levels of fitness and mental health in
people with serious mental illness.
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Table 4 Comparison: exercise versus standard care
Outcome or subgroup title No. of studies (available data) No. of participants Statistical method Effect Size (SWD)
Exercise activity 1 13 SMD (IV, Random, 95% CI) 1.81 [0.44 to 3.18]
BMI 4 151 SMD (IV, Random, 95% CI) −0.24 [−0.56 to 0.08]
Weight 2 77 SMD (IV, Random, 95% CI) 0.13 [−0.32 to 0.58]
Negative 2 84 SMD (IV, Random, 95% CI) −0.54 [−1.79 to 0.71]
Symptoms
Positive 2 84 SMD (IV, Random, 95% CI) −1.66 [−3.78 to 0.45]
Symptoms
Anxiety/Depression 3 94 SMD (IV, Random, 95% CI) −0.26 [−0.91 to 0.39]
Q of L (Physical) 2 30 SMD (IV, Random, 95% CI) 0.45 [−0.27 to 1.18]
Q of L (Mental) 2 30 SMD (IV, Random, 95% CI) 0.65 [−0.09 to 1.39]
Pearsall et al. BMC Psychiatry 2014, 14:117 Page 13 of 17
http://www.biomedcentral.com/1471-244X/14/117z = 1.22, p = 0.22: mental domain: n = 30, SMD = 0.65,
CI −0.09 to 1.39, z = 1.73, p = 0.08).
The final study compared the effect of adding specific
exercise advice and motivational skills to a simple walk-
ing programme [43]. No significant change was found in
the attendance at walking groups, persistence, or mi-
nutes walked compared with the control.
Methodological design and quality
The review found a lack of standardisation in terms of
the exercise intervention, setting and outcomes mea-
sures (Tables 1, 2 and 3). Six studies described an ad-
equate method of randomisation. Four out of the 8
studies used satisfactory methods to conceal the alloca-
tion of treatment. Beebe et al. [41] was the only study to
incorporate outcome assessors blinded to the treatment
group. There was considerable variation in sample size.
No study described a sample size calculation. We used
the Cochrane Collaboration’s tool for assessing the risk
of bias [40] (Figure 6).
One study only adequately addressed the analysis
of incomplete data [44]. Data was analysed on an intention-
to-treat basis with last observation carried forward on the
following measures, bodyweight, body mass index, and
waist circumference.
Levels of attrition varied in the included studies be-
tween 0% and 33% with a mean of 18.9%. No dropoutStudy or Subgroup
Marzolini 2009
Total (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.58 (P = 0.010)
Mean
563.7
SD
35
Total
7
7
Mean
484.2
SD
47
Total
6
6
Weight
100.0%
100.0%
Experimental Control
Figure 2 Effect of exercise versus usual care: 6-minute walking distanwas observed in two studies [44,46]. Methapatara et al.
[44] had no attrition in a larger study of 64 individuals,
perhaps suggesting that participants in this study were
more motivated to change.
Discussion
Exercise programmes found in this review had a modest
beneficial effect on levels of exercise activity. Exercise
did not lead to an improvement in body mass index,
negative or positive symptoms of schizophrenia, or the
individual’s quality of life. No effect was found on body
weight or symptoms of anxiety or depression. No benefi-
cial effect was found by the addition of specific exercise
advice with motivational techniques to a simple exercise
programme. The review found that many studies varied
in the type of exercise programme used, setting, age
group, sample size, and outcome measures. Comparison
of these outcomes proved difficult. Diversity of setting may
have had an impact on the delivery and generalisability of
the exercise interventions. Exercise change may be more
easily achievable within a more closely supervised setting
such as an inpatient ward.
The exercise programmes used a variety of outcome
measures. Only two studies used a validated measure of
exercise [41,46] the 6-Minute Walking Distance [50]. The
majority of studies did not measure the quantity or inten-
sity of the activity programme. It therefore proved difficultIV, Random, 95% CI
1.81 [0.44, 3.18]
1.81 [0.44, 3.18]
Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [experimental] Favours [control]
ce.
Study or Subgroup
Marzolini 2009
Methapatara 2011
Scheewe 2012
Skrinar 2005
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.45, df = 3 (P = 0.69); I² = 0%
Test for overall effect: Z = 1.47 (P = 0.14)
Mean
27.6
28.1
26.6
32.3
SD
1.1
1.3
5.8
7.6
Total
7
32
29
9
77
Mean
28.8
28.6
27.2
32.3
SD
1.9
1.55
6.2
4.1
Total
6
32
25
11
74
Weight
8.0%
42.5%
36.2%
13.4%
100.0%
IV, Random, 95% CI
-0.74 [-1.88, 0.41]
-0.35 [-0.84, 0.15]
-0.10 [-0.63, 0.44]
0.00 [-0.88, 0.88]
-0.24 [-0.56, 0.08]
Experimental Control Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [experimental] Favours [control]
Figure 3 Effect of exercise versus usual care: body mass index.
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could not estimate the amount of exercise required to
achieve an improvement in levels of exercise activity or
mental health symptoms.
Exercise programmes resulted in only moderate or lit-
tle change in measured outcomes. It is unclear why
these programmes did not lead to a more significant im-
provement. The physical activity component of the in-
terventions may not have been sufficiently intense. The
duration of the programme may have been too short to
bring about change. Delivery of the uptake of the ses-
sions may have been inadequate to achieve a change in
activity levels. The difficulties bringing about change in
this population may reflect the inherent problems in this
population. There are greater levels of smoking, weight
problems, and co-morbid illness [51]. Individuals with
greater risk factors and co-morbid physical illness may
have more difficulty achieving higher levels of physical
activity.
The review found that attrition levels were low with
one study having no drop-out of participants. Analysis
of dropout rates can give valuable information about pa-
tient characteristics and trial characteristics that affect
the overall uptake of an intervention [52]. Loss to follow
up after recruitment and attrition in randomised controlled
trials affects the generalisability and the reliability of their
results [52,53]. Studies of health-behaviour change [54] inStudy or Subgroup
Marzolini 2009
Methapatara 2011
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.07, df = 1 (P = 0.79); I² = 0%
Test for overall effect: Z = 0.57 (P = 0.57)
Mean
82.8
75.5
SD
3.5
3.58
Total
7
32
39
Mean
81.5
75.1
SD
5.5
4.08
Total
6
32
38
Weight
16.6%
83.4%
100.0%
Experimental Control
Figure 4 Effect of exercise versus usual care: weight.the general population have found varying levels of attri-
tion. Smoking cessation interventions have been found to
have attrition rates of up to 49%. Attrition rates of between
27% [55] and 32.8% [56] have been observed in weight loss
studies. In people with serious mental illness similar levels
of attrition have been found. Khan et al. [57] found in 45
trials of antidepressants with a total of 19,000 subjects the
mean drop out rate was 37%. Explanation for the low level
of attrition in this review is unclear. Low drop-out rates
may suggest the participation of motivated individuals will-
ing to change their behaviour. Several studies included indi-
viduals based in hospital wards. The structured setting of a
ward environment may have reduced the levels of attrition.
Despite the health problems of this population we
found only 8 randomised controlled trials assessing the
effectiveness of exercise programmes for people with
serious mental illness. However the number of studies in
this field has steadily grown over the past few years. For
example, Ellis et al. [58] in a systematic review of exer-
cise programmes in psychosis identified one randomised
controlled trial [41], while Gorczynski et al. [59] found
three studies [41,46,60] following a systematic search
completed in December 2008. However one of these
studies included the effects of yoga therapy in people
with schizophrenia [60]. A recent literature review by
Faulkner et al. [61] found a total of 7 randomised con-
trolled trials, however 4 of these included yoga therapy.IV, Random, 95% CI
0.27 [-0.83, 1.36]
0.10 [-0.39, 0.59]
0.13 [-0.32, 0.58]
Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [experimental] Favours [control]
Study or Subgroup
Acil 2008
Marzolini 2009
Scheewe 2012
Total (95% CI)
Heterogeneity: Tau² = 0.16; Chi² = 3.92, df = 2 (P = 0.14); I² = 49%
Test for overall effect: Z = 0.79 (P = 0.43)
Mean
0.5
65.5
9.7
SD
0.45
9
2
Total
15
4
29
48
Mean
0.98
58.1
10.7
SD
1.23
5.5
1.9
Total
15
6
25
46
Weight
36.8%
16.8%
46.4%
100.0%
IV, Random, 95% CI
-0.50 [-1.23, 0.22]
0.95 [-0.42, 2.33]
-0.50 [-1.05, 0.04]
-0.26 [-0.91, 0.39]
Experimental Control Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Favours [experimental] Favours [control]
Figure 5 Effect of exercise versus usual care: anxiety & depression.
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[48] which was included in the review in this paper.
It is unclear why so few studies have been conducted
in this field? In our review we found that many studies
were excluded as they contained additional components
such as dietary advice or measures to reduce weight.
The focus on physical activity alone may be being lost in
interventions designed to address the current increasing
general concerns about obesity and metabolic problems in
this population [61]. This is in addition to a general lack of
well designed studies aiming to address the health problems
and risk factors in this population. For example, smoking
levels in people with serious mental illness remain about
two to three times levels found in the general population.
However relatively few randomised trials have been con-
ducted with the primary aim of achieving smoking cessa-
tion in this population [62].
There are strengths and limitations to the results we
have presented. This review found modest changes in
levels of exercise activity, but no effect on symptoms
of mental health. A number of limitations need to be ac-
knowledged. Research in this field has been so far been lim-
ited with only a small number of randomised controlledRandom sequence generation (selection bias)
Allocation concealment (selection bias
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias
Selective reporting (reporting bias
Other bi
Low risk of bias Unclear risk of b
Figure 6 Risk of bias graph: review authors’ judgements about each risktrials. These tended to be small in size and of short dur-
ation. The heterogeneity of programmes affected the im-
pact and generalisability of studies found in the review.
Studies failed to quantify the amount and intensity of exer-
cise in their programmes. Interventions tended to use non-
standardised exercise programmes and a variety of outcome
measures. It proved difficult to recommend from this re-
view the most suitable and effective programme of exercise
to individuals with serious mental illness. Until further re-
search is conducted individuals with serious mental illness
should be encouraged to meet the general recommenda-
tions currently advised to the general population.
Research in the future needs to focus on methods to
improve levels of exercise in individuals with serious
mental illness. Programmes have proved successful in
the general population. There is a need to conduct
well designed randomised trials of physical activity
programmes. Research needs to incorporate a standar-
dised exercise programme and outcome assessment.
The duration and intensity of interventions needs to be
sufficient to achieve change in levels of physical activ-
ity, mental health symptoms, or weight. New pro-
grammes need to take into account the specific needs)
)
)
as
0% 25% 50% 75% 100%
ias High risk of bias
of bias item presented as percentages across all included studies.
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mental illness. Levels of motivation, mental health symp-
toms, and weight enhancing medication add additional
complexity and difficulties to this process. Potential barriers
to and benefits of physical activity for people with serious
mental illness have been shown in previous research.
McDevitt et al. [63] found that in individuals with serious
mental illness symptoms of mental illness (e.g. lack of en-
ergy or volition), medication, weight gain from medication,
and safety concerns restricted their ability to be active.
Johnstone et al. [64] found that limited experience of previ-
ous physical activity reduced self esteem and confidence,
and lack of structure or planning to their day, limited en-
gagement in exercise activity. In the review we described
three studies identified specific barriers affecting participa-
tion in their programmes. Marzolini et al. [50] found that
medical and health reasons, supervised trips and family
visits, and medical appointments affected participation.
Skrinar et al. [45] identified several barriers such as
problems with transport, financial issues, treatment fac-
tors, and conflicting schedules with other treatment
programmes affected participation. Beebe et al. [43]
found similar problems with the most common reasons
given for non-attendance being transportation problems
(22.2%), physical illness (20.6%), and conflict with an-
other appointment (12.7%).
For clinicians there remains no clear standardised
method to improve levels of physical activity in this
population. The health problems of this population
continue to be highlighted in many leading publica-
tions [1]. An effective method needs to be developed in
this population to reduce the persistently highs levels
of cardiovascular risk and mortality.
Conclusion
In conclusion we found that exercise programmes can lead to
an improvement in exercise activity but had no significant ef-
fect on symptoms of mental health or body weight. However,
it is clear that further research is needed with studies of larger
size using comparable interventions and outcome measures.
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